Cardiovascular outcomes in patients with type 2 diabetes who added either GLP1 receptor agonists or DPP4 inhibitors to SGLT2 inhibitor therapy
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)